Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease

Condition:   Alzheimer Disease Interventions:   Drug: Nilotinib BE 84mg;   Drug: Nilotinib BE 112 mg;   Drug: Placebo Sponsors:   KeifeRx, LLC;   Worldwide Clinical Trials;   Life Molecular Imaging GmbH;   Sun Pharmaceuticals Industries Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials